China approves first-ever functional cure for hepatitis B
By:Justus Hartmann China has approved the world’s first drug aimed at a functional cure of hepatitis B — a disease that affects more than 250 million people worldwide. The new therapy, Pegbing, developed by Amoytop Biotech in Xiamen, marks a breakthrough after decades of treatments that could control the virus but rarely silence it. A



